Clin2
NCT07680686Possibly a fitRecruiting

Study of ubrogepant tablets in healthy adults

Healthy Volunteer

Treatments studied

This trial studies how different forms of ubrogepant move through the body in healthy adults. It is designed to help find the best way to take the medication for future patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
52 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be a healthy adult between 18 and 55 years old.
  • Your body mass index (BMI) must be between 18 and 32.
  • You cannot have a history of seizures, heart problems, lung disease (except mild childhood asthma), kidney issues, liver disease, stomach problems, blood disorders, nerve conditions, mental health conditions, Raynaud's phenomenon, or any uncontrolled medical illness.
  • You cannot have a known allergy or sensitivity to any medication or food.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07277712Not yet recruiting· Phase 1
Study of IN-M00002 tablet in healthy adults

This trial tests how the body processes a new tablet called IN-M00002, and how food affects its absorption. It is for healthy volunteers to help find the right dose and understand side effects.

Jeonju
NCT05125302Recruiting· Phase 3
Ubrogepant for acute migraine relief in kids and teens

This study tests how safe ubrogepant is and whether it helps treat an individual migraine attack in children and teens. It focuses on measuring side effects and whether headaches improve 2 hours after taking the study medicine.

Huntsville, Alabama
NCT05127954Enrolling by invitation· Phase 3
Long-term migraine tablet study for kids and teens ages 6–17

This study follows kids and teens who already took part in an earlier migraine medication study to check long-term safety and comfort with oral ubrogepant tablets. It may help families understand whether this migraine tablet is safe to keep using over time.

Huntsville, Alabama
NCT07310290Recruiting
Study of Ubrogepant for Migraine During the Prodrome Phase

This study looks at how well the migraine medication ubrogepant works when taken during the early signs of a migraine (prodrome). It may help people who already use ubrogepant for their migraines.

Aliso Viejo, California
NCT07161180Recruiting· Phase 1
Study of PBK_M2301 in Healthy Adults

This trial tests how a new medicine, PBK_M2301, moves through the body in healthy adults. It aims to find out how the drug is absorbed and eliminated to guide future studies.

Seoul, Seoul
NCT07723833Recruiting· Phase 1
Study of different forms of elecoglipron in healthy volunteers

This trial tests how different versions of the drug elecoglipron are absorbed by the body and if they are safe. It is for healthy people to help find the best way to take the medicine.

Glendale, California

Hear when a new Healthy Volunteer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.